Page last updated: 2024-11-01

nifedipine and Leukoencephalopathy Syndrome, Posterior

nifedipine has been researched along with Leukoencephalopathy Syndrome, Posterior in 3 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research Excerpts

ExcerptRelevanceReference
"Typical posterior reversible encephalopathy syndrome (PRES) is a clinical-neuroradiological entity characterised by bilateral white matter oedema, which is usually symmetrical and totally reversible in 2-3 weeks."1.56Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement. ( De Angelis, MV; Di Stefano, V; Onofrj, M; Rispoli, MG, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Di Stefano, V1
Rispoli, MG1
Onofrj, M1
De Angelis, MV1
Vitucci, A1
Lojacono, A1
Gatti, E1
Prefumo, F1
Fratelli, N1
Forteza, A1
Echeverria, Y1
Haussen, DC1
Gutierrez, J1
Wiley, E1
De Gusmao, C1

Other Studies

3 other studies available for nifedipine and Leukoencephalopathy Syndrome, Posterior

ArticleYear
Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement.
    BMJ case reports, 2020, Jan-08, Volume: 13, Issue:1

    Topics: Antihypertensive Agents; Brain Stem; Calcium Channel Blockers; Diagnosis, Differential; Doxazosin; H

2020
Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019, Volume: 39, Issue:3

    Topics: Adult; Female; HELLP Syndrome; Humans; Magnesium Sulfate; Magnetic Resonance Imaging; Nifedipine; Po

2019
Cerebral vasomotor reactivity monitoring in posterior reversible encephalopathy syndrome.
    BMJ case reports, 2010, Oct-12, Volume: 2010

    Topics: Adrenergic beta-Antagonists; Adult; Anticonvulsants; Calcium Channel Blockers; Diagnosis, Differenti

2010